About The Company

The START Center for Cancer Research (START) is the world’s largest early phase site network, fully dedicated to oncology clinical research. With a rich history of advancing cancer treatment, START has provided hope to cancer patients across the globe by facilitating access to cutting‑edge clinical trials in the United States and Europe. The organization has successfully completed over 1,300 studies and operates research facilities in the United States, Spain, Portugal, and Ireland. START’s mission is to accelerate the development of new anticancer therapies aimed at improving patient quality of life and survival rates, ultimately striving for a cure. More than 43 therapies tested at START locations have received FDA or EMA approval, exemplifying its significant contribution to oncology research. While academic medical centers conduct 80% of cancer trials, these trials reach only 20% of the patient population, often leaving community practice patients ...